DPP4 and type 2 diabetes mellitus: Comparing to other oral antidiabetic medicines, such as DPP-4 inhibitor, acarbose and sulfonylurea and dapagliflozin, canagliflozin are likely to be a cost-effective alternative in adults with T2DM.